2-(3,5-dimethyl-1H-pyrazol-1-yl)-3-(2-morpholino-2-oxoethyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one结构式
|
常用名 | 2-(3,5-dimethyl-1H-pyrazol-1-yl)-3-(2-morpholino-2-oxoethyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one | 英文名 | 2-(3,5-dimethyl-1H-pyrazol-1-yl)-3-(2-morpholino-2-oxoethyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one |
|---|---|---|---|---|
| CAS号 | 1007279-40-4 | 分子量 | 357.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H23N5O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-(3,5-dimethyl-1H-pyrazol-1-yl)-3-(2-morpholino-2-oxoethyl)-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one |
|---|
| 分子式 | C18H23N5O3 |
|---|---|
| 分子量 | 357.4 |
| InChIKey | WSUDGPVWKICWIP-UHFFFAOYSA-N |
| SMILES | Cc1cc(C)n(-c2nc3c(c(=O)n2CC(=O)N2CCOCC2)CCC3)n1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|